IRadimed Corp
SWB:46K

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
SWB:46K
Watchlist
Price: 79 EUR -3.66% Market Closed
Market Cap: €1B

Intrinsic Value

The intrinsic value for IRadimed Corp (46K) under the Base Case is hidden EUR. Compared with the current market price of 79 EUR, the stock appears hidden .

Intrinsic value calculated using DCF
Locked

Do our valuations actually work? See backtest results .

46K Intrinsic Value
LOCKED
Unlock
Today vs. history

46K looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with 46K’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 46K
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €79
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about 46K?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 46K valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for IRadimed Corp.

Explain Valuation
Alternatives to 46K

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

IRMD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 46K stock?

The intrinsic value for IRadimed Corp (46K) under the Base Case is hidden EUR.

Is 46K stock undervalued or overvalued?

Compared with the current market price of 79 EUR, the stock appears hidden.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett